Earnings
TOUAX Swings to €4.2M Half-Year Loss as Revenue Drops 13%
The French leasing group posted a first-half net loss of €4.2m on revenue of €72.9m, while Trinity Industries took a 32% stake in its Indian rail unit.
News from SEC filings, FDA decisions and company releases, drafted with AI and checked by an editor before publication. How we work: redfiled.com/how-we-work/
Earnings
The French leasing group posted a first-half net loss of €4.2m on revenue of €72.9m, while Trinity Industries took a 32% stake in its Indian rail unit.
TGL
Treasure Global subsidiary Tadaa Technology won a US$52 million partnership to roll out the EzyTrace agricultural supply chain platform for Malaysia's government.
XCUR
Exicure has until December 2, 2026 to show at least $2.5 million in stockholders' equity or face a delisting determination it could appeal.
Regulatory
Isku Inspira, holding 10.37% of Martela's shares, wants an EGM on a special audit of the Finnish furniture maker's accounts and its planned directed share issue.
ASO
Board member Brian T. Marley sold 10,432 Academy Sports & Outdoors shares on the open market on September 15, leaving him with 32,607 shares.
EZRA
The InsurTech company closed the sale of Southwestern Montana Insurance Center at 8.75 times pro forma EBITDA, with an uncapped earnout and no dilution.
MYSZ
My Size agreed to sell stock and pre-funded warrants at $1.91 apiece, paired with two series of warrants, with H.C. Wainwright as placement agent.
AEHL
The Chinese livestreaming e-commerce group issued an 8.00% convertible note to one accredited investor, convertible at 80% of the lowest three-day VWAP.
CRML
An Australian court has cleared European Lithium to convene shareholder and optionholder meetings on Critical Metals' takeover, with the scheme booklet now registered.
CRWV
Blockfusion converted its June letter of intent with CoreWeave into a definitive 15-year anchor lease, a step toward its Nasdaq listing via Blue Acquisition Corp.
ARTL
Nonclinical study showed roughly 20% weight loss on Artelo's oral cannabinoid agonist alone and about 40% when combined with semaglutide.
INMD
The non-binding bid that M.N. Business Strategy submitted in June lapsed on September 15, and InMode says no agreement was reached.